- Home
- RSSS vs PSNL Comparison
RSSS vs PSNL Comparison
Compare RSSS & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSSS
- PSNL
- Stock Information
- Founded
- RSSS 2006
- PSNL 2011
- Country
- RSSS United States
- PSNL United States
- Employees
- RSSS N/A
- PSNL N/A
- Industry
- RSSS Business Services
- PSNL Medical Specialities
- Sector
- RSSS Consumer Discretionary
- PSNL Health Care
- Exchange
- RSSS Nasdaq
- PSNL Nasdaq
- Market Cap
- RSSS 110.0M
- PSNL 518.8M
- IPO Year
- RSSS N/A
- PSNL 2019
- Fundamental
- Price
- RSSS $3.29
- PSNL $9.78
- Analyst Decision
- RSSS Strong Buy
- PSNL Strong Buy
- Analyst Count
- RSSS 1
- PSNL 5
- Target Price
- RSSS $5.00
- PSNL $8.70
- AVG Volume (30 Days)
- RSSS 76.2K
- PSNL 1.3M
- Earning Date
- RSSS 11-13-2025
- PSNL 11-04-2025
- Dividend Yield
- RSSS N/A
- PSNL N/A
- EPS Growth
- RSSS N/A
- PSNL N/A
- EPS
- RSSS 0.04
- PSNL N/A
- Revenue
- RSSS $49,057,981.00
- PSNL $80,317,000.00
- Revenue This Year
- RSSS $5.79
- PSNL N/A
- Revenue Next Year
- RSSS $8.46
- PSNL $29.83
- P/E Ratio
- RSSS $82.25
- PSNL N/A
- Revenue Growth
- RSSS 9.94
- PSNL 0.36
- 52 Week Low
- RSSS $2.32
- PSNL $2.83
- 52 Week High
- RSSS $4.24
- PSNL $10.95
- Technical
- Relative Strength Index (RSI)
- RSSS 45.00
- PSNL 64.92
- Support Level
- RSSS $3.19
- PSNL $8.53
- Resistance Level
- RSSS $3.54
- PSNL $10.95
- Average True Range (ATR)
- RSSS 0.14
- PSNL 0.91
- MACD
- RSSS -0.04
- PSNL 0.05
- Stochastic Oscillator
- RSSS 27.41
- PSNL 67.37
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.